Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
FDA review determines that long-term use of clopidogrel does not increase/decrease overall risk of death in patients with, or at risk for, heart disease, and does not suggest that clopidogrel increases risk of cancer/death from cancer.
Source: FDA MedWatch - Category: American Health Source Type: news
More News: American Health | Cancer | Cancer & Oncology | Cardiology | Clopidogrel | Heart | Heart Disease | Plavix